Loading, please wait...
.webp&w=384&q=75){kind=logo}
Verifying...
Loading, please wait...
"Wherever the art of Medicine is loved, there is also a love of Humanity."
— Hippocrates
Researchers recently developed a novel approach using chloramphenicol transfersome delivery to treat eye infections. Specifically, they focused on applying these formulations directly onto the eyelid skin. Consequently, this method aims to bypass traditional ocular barriers. Furthermore, the study utilized transfersomes with an average size of 120 nm. Because these vesicles are monodispersed, they ensure uniform drug distribution. Moreover, this innovation could revolutionize how we manage bacterial conjunctivitis in clinical settings.
These ultra-deformable vesicles offer several clinical advantages. However, traditional eye drops often wash away quickly. In contrast, transfersomes penetrate the eyelid skin to reach the conjunctiva. Therefore, this system provides a sustained therapeutic effect. Additionally, the non-invasive nature improves patient compliance significantly. Ultimately, clinicians can expect better outcomes with reduced dosing frequency.
The skin of the eyelid acts as a gatekeeper for topical medications. Similarly, the unique composition of transfersomes allows them to squeeze through the stratum corneum. Hence, the drug reaches the infection site without direct irritation to the eyeball. Notably, this method reduces systemic side effects by focusing on local delivery. As a result, it provides a safer alternative for sensitive populations like children.
Transfersomes contain edge activators that make them ultra-deformable. Consequently, they can squeeze through tiny pores in the skin more effectively than rigid liposomes. This enhances drug penetration significantly.
Eyelid application allows the drug to penetrate the skin and reach the conjunctiva locally. Therefore, it reduces the discomfort and rapid drainage issues associated with traditional eye drops. This ensures a higher concentration of the drug stays at the target site.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Grygor'yeva L et al. Chloramphenicol Application Onto the Eyelid: Transfersomes for Enhanced Skin Delivery. AAPS PharmSciTech. 2026 Jun 11. doi: undefined. PMID: 42277546.
Vyavahare SS, et al. Chloramphenicol Overview in Eye Infections. International Journal of Pharmacy & Pharmaceutical Research. 2024; 30(5): 72-84.
Dua A, et al. Transfersomes: A Vesicular Tool for Transdermal Drug Delivery. Innovative Lipid-Based Vesicles. 2026.
Link will be sent via SMS to your number.
Researchers have developed chloramphenicol-loaded transfersomes (120 nm) to treat conjunctivitis via eyelid application. This novel delivery system enhances drug permeability and stability, offering a promising non-invasive alternative to traditional eye drops for managing ocular infections.
Today
A landmark study published in Cell Genomics reveals that overcrowding, poor sanitation, and socioeconomic inequality are primary drivers of global antimicrobial resistance. Reducing antibiotic consumption alone will not suffice, highlighting the urgent need for structural public health reforms by 2050.
Today
A new study reveals that hyperactivating the Hedgehog pathway with Smoothened Agonist (SAG) causes significant craniofacial development defects in mice. By disrupting cell proliferation and cell-cycle progression during a critical window, SAG exposure leads to cleft lip and other cranial abnormalities.
Today
A study of 221 patients reveals that IVUS guidance during intracoronary brachytherapy for in-stent restenosis significantly reduces target lesion revascularization (21% vs 37%) and major adverse cardiovascular events, ensuring better long-term procedural success and improved patient safety.
Today
Despite their expertise in ergonomics, physiotherapists face high rates of work-related musculoskeletal disorders. New research identifies low back pain and repetitive tasks as leading issues, with female practitioners showing significantly higher risk profiles compared to their male counterparts.
Today
A comprehensive pathological study reveals that medial and intimal calcification follow distinct, inverse distribution patterns in the lower extremities, with medial calcification significantly linked to chronic kidney disease.
Today